| Current Price | $10.21 | Mkt Cap | $1.8B |
|---|---|---|---|
| Open | $10.38 | P/E Ratio | 0.00 |
| Prev. Close | $10.21 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $10.19 - $10.56 | Volume | 2,183,967 |
| 52-Wk Range | $2.24 - $14.24 | Avg. Daily Vol. | 6,481,963 |
A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.
| Current Price | $10.21 | Mkt Cap | $1.8B |
|---|---|---|---|
| Open | $10.38 | P/E Ratio | 0.00 |
| Prev. Close | $10.21 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $10.19 - $10.56 | Volume | 2,183,967 |
| 52-Wk Range | $2.24 - $14.24 | Avg. Daily Vol. | 6,481,963 |
The best Bull and Bear pitches based on recency and number of recommendations.
As I predicted, BioCryst still had a little life left which allowed me to escape my green thumb and flip turn into a red one. 33% jump today, and all because of this:BioCryst Pharmaceuticals, Inc. today announced that it received a preliminary… More
Read the most recent pitches from players about BCRX.
Recs
PensionExtender
(34.70)
Submitted: 6/30/2020 5:50:50 PM :
Start Price:
$4.90
NASDAQ:BCRX Score:
+75.49
COVID-19 biotech should continue to grow with oral delivery system of vaccine
Recs
mdriver78
(76.05)
Submitted: 5/8/2020 1:14:04 PM :
Start Price:
$4.36
NASDAQ:BCRX Score:
+97.30
Expecting positive sales of over $500 on Berotralstat approval. Plus early clinical data supports BCX9930 as oral monotherapy for complement-mediated diseases plus patient dosing underway in galidesivir trial in COVID-19 patients in Brazil. All sounds quite positive and worth a flyer.
Recs
FVelociraptor
(49.44)
Submitted: 11/13/2019 6:03:19 PM :
Start Price:
$1.61
NASDAQ:BCRX Score:
-500.90
https://velociraptor.cc
Find the members with the highest scoring picks in BCRX.
Chemnerd (39.63) Score: +564.96
The Score Leader is the player with the highest score across all their picks in BCRX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| cozynite | 24.19 | 3/14/2013 |
|
5Y | $1.31 | +679.39% | +162.55% | +516.84 | 0 Comment | |
| MrTwo94 | 88.61 | 11/8/2012 |
|
1Y | $1.37 | +645.26% | +194.51% | +450.75 | 0 Comment | |
| jgrnot | 24.10 | 12/4/2012 |
|
5Y | $1.41 | +624.16% | +191.13% | +433.03 | 0 Comment | |
| Sytes | < 20 | 5/29/2013 |
|
3Y | $1.60 | +538.12% | +148.75% | +389.37 | 1 Comment | |
| bearonwallstreet | 65.15 | 5/16/2013 |
|
5Y | $1.70 | +500.59% | +148.21% | +352.37 | 0 Comment | |
| warrenout3 | 40.66 | 12/3/2012 |
|
5Y | $1.63 | +526.38% | +188.16% | +338.22 | 0 Comment | |
| portefeuille2 | 98.95 | 2/16/2016 |
|
5Y | $1.87 | +445.99% | +116.94% | +329.05 | 0 Comment | |
| KeepYourCoolFool | 95.10 | 7/29/2009 |
|
5Y | $10.58 | -3.50% | +323.78% | +327.27 | 0 Comment | |
| BASSTRAX | 30.27 | 8/31/2009 |
|
1Y | $12.99 | -21.40% | +305.40% | +326.80 | 0 Comment | |
| DRASH5 | 47.15 | 7/29/2009 |
|
3W | $10.28 | -0.68% | +325.08% | +325.77 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
